Wordt geladen...
Frequency of Hospitalized Infections Is Reduced in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs after 2010
BACKGROUND: Biological disease-modifying antirheumatic drugs (bDMARDs) and targeted synthetic (ts) DMARDs are important in rheumatoid arthritis (RA) treatment. The risk of hospitalized infection associated with bDMARDs/tsDMARDs in RA patients is unclear. METHODS: We retrospectively analyzed the case...
Bewaard in:
| Gepubliceerd in: | J Immunol Res |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Hindawi
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6112083/ https://ncbi.nlm.nih.gov/pubmed/30186881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/6259010 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|